act-2001-0-96•Pennsylvania Act 2001-96 — BLOODBORNE PATHOGEN STANDARD ACT
Pennsylvania Act 2001-96 — BLOODBORNE PATHOGEN STANDARD ACT
act-2001-0-962001 Pa. Act 96Law
Act text
BLOODBORNE PATHOGEN STANDARD ACT
Act of Dec. 13, 2001, P.L. 873, No. 96 Cl. 35
AN ACT
Requiring the Department of Health to establish bloodborne
pathogen standards for public employees.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Short title.
This act shall be known and may be cited as the Bloodborne
Pathogen Standard Act.
Section 2. Definitions.
The following words and phrases when used in this act shall
have the meanings given to them in this section unless the
context clearly indicates otherwise:
"Bloodborne pathogen." A pathogenic microorganism which is
present in human blood and can cause disease in humans. The term
includes hepatitis B virus (HBV), hepatitis C virus (HCV) and
human immunodeficiency virus (HIV).
"Department." The Department of Health of the Commonwealth.
"Employer." An employer having public employees whose duties
could reasonably result in occupational exposure to blood or
other material potentially containing a bloodborne pathogen.
"Engineered sharps injury protection." Any of the following:
(1) A physical attribute built into a needle device used
for withdrawing body fluids, accessing a vein or artery or
administering medications or other fluids which effectively
reduces the risk of exposure to bodily fluid by a mechanism
such as barrier creation, blunting, encapsulation,
withdrawal, retraction, destruction or other effective
mechanisms.
(2) A physical attribute built into any other type of
needle device or into a nonneedle sharp which effectively
reduces the risk of exposure to bodily fluid.
"Needleless system." A device which does not utilize needles
for:
(1) the withdrawal of body fluids after initial venous
or arterial access is established;
(2) the administration of medication or fluids; or
(3) any other procedure involving the potential for
exposure to bodily fluid.
"Public employee." An employee of the Commonwealth or a
political subdivision employed in a health care facility, home
health care organization or other facility providing health
care-related services:
(1) whose activities involve contact with a patient or
with blood or other body fluid from a patient in a health
care or laboratory setting; or
(2) who is responsible for direct patient care with
potential occupational exposure to a sharps injury.
The term does not include a licensed individual who provides
only intraoral care.
"Sharp." An object used or encountered in a health care
setting which can be reasonably anticipated to penetrate the
skin or any other part of the body and to result in exposure to
bodily fluid. The term includes a needle device, scalpel or
lancet, broken glass or a broken capillary tube.
"Sharps injury." An injury caused by a sharp and resulting
in exposure to bodily fluid. The term includes any cut, abrasion
or needlestick.
"Sharps injury log." A written or electronic record of
sharps injuries.
Section 3. Department.
(a) Adoption of standard.--Within six months of the
effective date of this act, the department shall adopt a
bloodborne pathogen standard governing public employees. The
standard shall be at least as prescriptive as the standard
promulgated by the Federal Occupational Safety and Health
Administration and shall include the following:
(1) A requirement that needleless systems and sharps
with engineered sharps injury protection be included as
engineering and work practice controls. Engineering controls
under this paragraph shall not be required if none is
available in the marketplace.
(2) A requirement that each public employee receive
education on the use of an engineering control before a
control is introduced into the clinical setting.
(3) A requirement that each employer develop and
implement an effective written exposure control plan which
includes procedures for all of the following:
(i) Updating the written exposure control plan when
necessary, but at least once each year, to reflect
progress in implementing needleless systems and sharps
with engineered sharps injury protection.
(ii) Recording information concerning exposure to
bodily fluid in a sharps injury log. This subparagraph
includes:
(A) Date and time of the exposure.
(B) Type and brand of sharp involved in the
exposure.
(C) Description of the exposure. This clause
includes:
(I) Job classification of the exposed public
employee.
(II) Department or work area where the
exposure occurred.
(III) Procedure which the exposed public
employee was performing at the time of the
exposure.
(IV) How the exposure occurred.
(V) Body part involved in the exposure.
(VI) If the sharp had engineered sharps
injury protection, whether the protective
mechanism was activated and whether the injury
occurred before the protective mechanism was
activated, during activation of the mechanism or
after activation of the mechanism.
(VII) If the sharp had no engineered sharps
injury protection, whether and how such a
mechanism could have prevented the injury. This
subclause requires statement of the basis for the
assessment.
(VIII) An assessment of whether any other
engineering, administrative or work practice
control could have prevented the injury. This
subclause requires statement of the basis for the
assessment.
(b) Additional measures.--The department shall consider
additional measures to prevent sharps injuries or exposure to
bodily fluid. This subsection includes training and educational
requirements, increased use of vaccinations, strategic placement
of sharps containers as close to the work area as practical and
increased use of personal protective equipment.
(c) Regulations.--The department may promulgate regulations
to implement this act.
Section 4. Employers.
(a) Complaints.--Each employer shall develop and implement
compliance monitoring procedures and a complaint process.
(b) Review.--Each employer shall provide its public
employees an opportunity to evaluate engineered sharps injury
prevention devices and needleless systems in an accident and
illness prevention program.
Section 5. Implementation.
The use of a drug or biologic which is prepackaged with an
administration system or used in a prefilled syringe and is
approved for commercial distribution or investigational use by
the United States Food and Drug Administration is exempt from
standards adopted under this act for a period of three years
from the effective date of this act.
Section 6. Applicability to contractors.
Nothing in this act shall prohibit an employer from applying
the principles of this act to a contractor.
Section 7. Effective date.
This act shall take effect in 120 days.
Continue sua pesquisa no ChatGPT ou Claude
Conecte o Omnilex para pesquisar o corpus jurídico pelo seu assistente de IA.